Advertisement

Topics

Access Pharmaceuticals, Inc. Company Profile

08:34 EST 21st February 2019 | BioPortfolio

Access Pharmaceuticals, Inc. is an emerging biopharmaceutical company that develops and commercializes proprietary products for the treatment and supportive care of cancer patients. Access' products include ProLindac(TM), currently in Phase II clinical testing of patients with ovarian cancer, and MuGard(TM) for the management of patients with mucositis. The company also has other advanced drug delivery technologies including Cobalamin(TM)-mediated targeted delivery and oral drug delivery, its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism and Thiarabine, a new generation nucleoside analog which has demonstrated both pre-clinical and clinical activity in certain cancers. For additional information on Access Pharmaceuticals, please visit our website at www.accesspharma.com.


News Articles [521 Associated News Articles listed on BioPortfolio]

M&As this week: Ligand Pharmaceuticals, CVS Health, Mundipharma

Ligand Pharmaceuticals has acquired Vernalis for $42.3m giving the former access to a portfolio of eight fully funded programmes, as...Read More... The post M&As this week: Ligand Pharmaceuticals...

Weekend Links

Spouse vs. patient preferences for nursing homes. Food swamps. Medicaid and moral hazard. Medicare access to anti-opioid medications. The price ain’t right. Brexit and access to pharmaceuticals. Cur...

Opinion: It is time to start focusing on balancing access to pharmaceuticals today with access to new drugs in the future. https://buff.ly/2FwqLZx 

Opinion: It is time to start focusing on balancing access to pharmaceuticals today with access to new drugs in the future. https://buff.ly/2FwqLZx 

Actinium Pharmaceuticals Inc (ATNM-US): Improving -2-

DJ Actinium Pharmaceuticals Inc (ATNM-US): Improving access to CAR-T Dow Jones received a payment from EQS/DGAP to publish this press release. goetzpartners securities Limited Actinium Pharmaceuti...

Conatus Pharmaceuticals Inc. (CNAT) Upcoming Presentations, Analysts Review and Target

Conatus Pharmaceuticals, Upcoming Presentations, Analysts Review and Target Traders News Source, a leading independent equity research, and corporate access firm focused on small and mid-cap public co...

Nexus Pharmaceuticals gets FDA nod for Arsenic Trioxide injection in 10mg per 10mL vial

Nexus Pharmaceuticals chief commercial officer Omair Ahmed said: “The approval of generic Arsenic Trioxide injection continues to show Nexus’s commitment in providing access to affordable critical...

STAT Plus: Italy urges transparency on pricing in order to widen access to pharmaceuticals. https://buff.ly/2GrX3ps 

STAT Plus: Italy urges transparency on pricing in order to widen access to pharmaceuticals. https://buff.ly/2GrX3ps 

STAT Plus: The ongoing row over access in the U.K. to a Vertex Pharmaceuticals cystic fibrosis treatment has taken an unexpected twist. https://buff.ly/2GfyKdz 

STAT Plus: The ongoing row over access in the U.K. to a Vertex Pharmaceuticals cystic fibrosis treatment has taken an unexpected twist. https://buff.ly/2GfyKdz 

Drugs and Medications [61 Associated Drugs and Medications listed on BioPortfolio]

Cpda-1 [fenwal, inc.]

Anticoagulant Citrate Phosphate Dextrose Adenine Solution, USP (CPDA-1) BLOOD-PACK™ Unit

Cpda-1 [fenwal, inc.]

Anticoagulant Citrate Phosphate Dextrose Adenine Solution, USP (CPDA-1) BLOOD-PACK™ Unit

Cpda-1 [fenwal, inc.]

Anticoagulant Citrate Phosphate Dextrose Adenine Solution, USP (CPDA-1) BLOOD-PACK™ Unit

Cpda-1 [fenwal, inc.]

Anticoagulant Citrate Phosphate Dextrose Adenine Solution, USP (CPDA-1) BLOOD-PACK™ Unit

Cpda-1 [fenwal, inc.]

Anticoagulant Citrate Phosphate Dextrose Adenine Solution, USP (CPDA-1) BLOOD-PACK™ Unit

PubMed Articles [806 Associated PubMed Articles listed on BioPortfolio]

Efficient access to deuterated and tritiated nucleobase pharmaceuticals and oligonucleotides using hydrogen isotope exchange.

A general approach for the nucleobase derivatives hydrogen isotope exchange is described. Catalyzed by ruthenium nanoparticles, using mild reaction conditions and involving D2 or T2 as isotopic source...

Drug sourcing and motivations among a sample of people involved in the supply of pharmaceutical drugs in Australia.

The non-medical use (NMU) of pharmaceuticals is increasing internationally, along with mortality. Previous research indicates that end-users access pharmaceuticals through social networks, however lit...

Swimming activity in zebrafish larvae exposed to veterinary antiparasitic pharmaceuticals.

Veterinary antiparasitic pharmaceuticals have been detected in surface waters and several of these pharmaceuticals act on the nervous system on the target organisms implying that neurological effects ...

Effectiveness of National Pricing Policies for Patent-Protected Pharmaceuticals in the OECD: A Systematic Literature Review.

The aim of this review is to assess the current state of empirical research regarding the effectiveness of national pricing regulations of the patent-protected market for prescription pharmaceuticals....

Insight into the distribution of pharmaceuticals in soil-water-plant systems.

Pharmaceuticals in agricultural soils originating from irrigation with treated wastewater and land-applied biosolids can enter field crops. However, little is known about the role of pore water in pla...

Clinical Trials [1838 Associated Clinical Trials listed on BioPortfolio]

Expanded Access to Omaveloxolone for Melanoma for Patients Previously Enrolled in 408-C-1401

This is an expanded access program for eligible participants and is designed to provide access to omaveloxolone for the treatment of unresectable or metastatic melanoma to patients who pre...

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

A Continued Access Protocol to Provide Xolair to Patients With Severe Allergic Asthma

This is a continued access protocol to provide subjects who have completed Genentech, Inc. Study Q2143g, Q2195g, or Q2461g or Novartis Pharmaceuticals Corporation Study CIGE025 0010E1 with...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Companies [2217 Associated Companies listed on BioPortfolio]

Access Pharmaceuticals, Inc.

Access Pharmaceuticals, Inc. is an emerging biopharmaceutical company that develops and commercializes proprietary products for the treatment and supportive care of cancer patients. Access' products i...

Access Pharmaceuticals

Access Pharmaceuticals is an emerging biotechnology company focused on the development and commercialization of products using the companies targeted delivery systems to improve clinical outcomes for ...

Lif inviterer sammen

Lif’s vision:The value of pharmaceuticals to be visible to Danish society and recognised in a patient-centric public health service the pharmaceutical industry to be perceived as a responsible partn...

Access Business Group LLC

Welcome to Access Business Group.Whether you need a reliable supplier or extra capacity solutions, count on Access Business Group for high service levels and quick turnaround.Financially stable, the h...

NovoBiotic Pharmaceuticals, LLC

NovoBiotic Pharmaceuticals is a privately held, early stage pharmaceutical company focused on the development of novel antibiotics.The Company’s founding scientists, Northeastern University professo...

More Information about "Access Pharmaceuticals, Inc." on BioPortfolio

We have published hundreds of Access Pharmaceuticals, Inc. news stories on BioPortfolio along with dozens of Access Pharmaceuticals, Inc. Clinical Trials and PubMed Articles about Access Pharmaceuticals, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Access Pharmaceuticals, Inc. Companies in our database. You can also find out about relevant Access Pharmaceuticals, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...


Corporate Database Quicklinks



Searches Linking to this Company Record